DaVita Inc.

NYSE:DVA

Medical - Care Facilities

Healthcare
$161.79 +0.77%

+$1.60 today

Market cap
$10.18B
Beta
0.91
P/E (TTM)
18.2
EPS (TTM)
$11.60
52W Low $101.00High $213.44

Volume 1.12M

Average 0.84M

DVA Net Income

Bottom-line profit, the starting point for calculating cash from operations.

DaVita Inc.NYSE: DVA

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income growth accelerates

Q2 FY2026 net income of $343.22M rose 24.7% year over year, ahead of the +16.2% change in trailing-twelve-month net income. Sequentially, it rose 24.8% from the prior quarter. Over 3 fiscal years it compounded at +11.3% a year.

Context

  • Net income amounted to 7.9% of revenue in FY2025, down 1.9 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 5 analysts of $1.13B (+4.5%) for the fiscal year ending Dec 2026, a step up from the -13.8% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$343.22M+24.8% QoQ
Last fiscal yearDec 2025
$1.08B-13.8% YoY
LTMJun 2026
$1.26B+16.2% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+24.7%-24.4%-49.1 pp
1 year-13.8%+4.5%+18.2 pp
3-year CAGR+11.3%+11.2%-0.1 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
1.08B USD
Year-over-year change
-13.8%
4-year CAGR
-2.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How DVA compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +16.2% is the lowest of 3, against a peer median of +173.7%.
  • Net income amounts to 9.0% of revenue for DVA, versus a peer median of 7.0%.
DVA Competitors
Net Income for DVA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DVADaVita Inc.LTM Jun 2026$1.26B USD+16.2%+11.3%9.0%
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€1.06B EUR+42.9%+1.7%5.5%
BAXBaxter International Inc.LTM Jun 2026$975M USD+304.6%-32.5%8.5%
Peer median (excluding DVA) —+173.7%-15.4%7.0%

Competitors are the stored peer set for DVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.21B781.64M691.54M1.25B1.08B
Depreciation & Amortization680.62M732.6M745.44M723.86M715.35M
Deferred Income Tax60.48M(75.67M)(39.35M)(57.84M)86.57M
Stock-Based Compensation102.21M95.43M112.38M102.79M139.95M
Change in Working Capital(140.64M)101K194.54M(29.82M)(263.24M)
Accounts Receivables(138.14M)(148.39M)172.36M(29.77M)(210.63M)
Inventory5.72M(757K)(32.13M)17.94M(19.95M)
Accounts Payables(30.32M)87.48M26.89M1.7M128.3M
Other Working Capital22.1M61.77M27.42M(19.7M)(160.96M)
Other Non-Cash Items16.45M30.47M354.5M32.31M129.15M
Operating Cash Flow1.93B1.56B2.06B2.02B1.89B
Capital Expenditures(641.47M)(603.43M)(567.99M)(555.44M)(575.86M)
Acquisitions (Net)(200.97M)(89.19M)(26.39M)(251.27M)(144.5M)
Purchases of Investments(33.84M)(133.39M)(322.95M)(24.46M)(22.44M)
Sales of Investments27.88M74.91M110M27.2M52.14M
Other Investing Activities63.66M120.76M35.52M32.54M35.71M
Investing Cash Flow(784.73M)(630.35M)(771.8M)(771.43M)(654.95M)
Debt Repayment754.26M(11.28M)(552.62M)1.11B769.62M
Common Stock Issued018.58M16.9M20.45M23.29M
Common Stock Repurchased(1.6B)(802.23M)(272.22M)(1.39B)(1.79B)
Dividends Paid00000
Other Financing Activities(238.59M)(326.2M)(362.56M)(560.56M)(374.69M)
Financing Cash Flow(1.08B)(1.12B)(1.17B)(816.94M)(1.37B)
Effect of Forex Changes(10.01M)(29.07M)8.91M(18.48M)21.15M
Net Change in Cash53.17M(215.97M)125.65M415.19M(122.08M)
Free Cash Flow1.29B961.14M1.49B1.47B1.31B

DaVita Inc.

NYSE:DVA

Intrinsic Alpha fair value

Locked

Current Price

$161.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.